nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—CYP1B1—esophageal cancer	0.197	0.484	CbGaD
Daunorubicin—ABCC2—esophageal cancer	0.153	0.377	CbGaD
Daunorubicin—ABCC6—Cisplatin—esophageal cancer	0.0889	0.217	CbGbCtD
Daunorubicin—XDH—Carboplatin—esophageal cancer	0.065	0.159	CbGbCtD
Daunorubicin—ABCB1—esophageal cancer	0.0564	0.139	CbGaD
Daunorubicin—XDH—Cisplatin—esophageal cancer	0.0556	0.136	CbGbCtD
Daunorubicin—ABCC10—Methotrexate—esophageal cancer	0.0441	0.108	CbGbCtD
Daunorubicin—SLC22A2—Cisplatin—esophageal cancer	0.0238	0.0581	CbGbCtD
Daunorubicin—ABCC2—Carboplatin—esophageal cancer	0.0227	0.0555	CbGbCtD
Daunorubicin—ABCG2—Carboplatin—esophageal cancer	0.0205	0.0502	CbGbCtD
Daunorubicin—ABCC2—Cisplatin—esophageal cancer	0.0194	0.0475	CbGbCtD
Daunorubicin—ABCG2—Cisplatin—esophageal cancer	0.0176	0.0429	CbGbCtD
Daunorubicin—ABCC1—Methotrexate—esophageal cancer	0.017	0.0416	CbGbCtD
Daunorubicin—ABCC2—Methotrexate—esophageal cancer	0.0126	0.0308	CbGbCtD
Daunorubicin—ABCG2—Methotrexate—esophageal cancer	0.0114	0.0279	CbGbCtD
Daunorubicin—ABCB1—Cisplatin—esophageal cancer	0.00633	0.0155	CbGbCtD
Daunorubicin—ABCB1—Methotrexate—esophageal cancer	0.00411	0.01	CbGbCtD
Daunorubicin—YWHAG—bronchus—esophageal cancer	0.000993	0.0399	CbGeAlD
Daunorubicin—YWHAG—smooth muscle tissue—esophageal cancer	0.000971	0.039	CbGeAlD
Daunorubicin—TOP2B—bronchus—esophageal cancer	0.000957	0.0384	CbGeAlD
Daunorubicin—TOP2B—smooth muscle tissue—esophageal cancer	0.000936	0.0376	CbGeAlD
Daunorubicin—YWHAG—trachea—esophageal cancer	0.000891	0.0358	CbGeAlD
Daunorubicin—TOP2B—trachea—esophageal cancer	0.000859	0.0345	CbGeAlD
Daunorubicin—YWHAG—digestive system—esophageal cancer	0.000767	0.0308	CbGeAlD
Daunorubicin—POR—bronchus—esophageal cancer	0.000755	0.0303	CbGeAlD
Daunorubicin—XDH—digestive system—esophageal cancer	0.000748	0.0301	CbGeAlD
Daunorubicin—TOP2B—digestive system—esophageal cancer	0.000739	0.0297	CbGeAlD
Daunorubicin—Doxorubicin—NOS3—esophageal cancer	0.000731	0.273	CrCbGaD
Daunorubicin—ABCB11—digestive system—esophageal cancer	0.000731	0.0294	CbGeAlD
Daunorubicin—Doxorubicin—NOS2—esophageal cancer	0.000706	0.264	CrCbGaD
Daunorubicin—TOP2A—bronchus—esophageal cancer	0.000703	0.0283	CbGeAlD
Daunorubicin—ABCC6—lung—esophageal cancer	0.00068	0.0273	CbGeAlD
Daunorubicin—POR—trachea—esophageal cancer	0.000678	0.0272	CbGeAlD
Daunorubicin—YWHAG—lung—esophageal cancer	0.00064	0.0257	CbGeAlD
Daunorubicin—TOP2B—lung—esophageal cancer	0.000617	0.0248	CbGeAlD
Daunorubicin—Doxorubicin—CYP1B1—esophageal cancer	0.0006	0.224	CrCbGaD
Daunorubicin—ABCC10—bronchus—esophageal cancer	0.000599	0.0241	CbGeAlD
Daunorubicin—SLC22A2—digestive system—esophageal cancer	0.000586	0.0236	CbGeAlD
Daunorubicin—Pericarditis—Methotrexate—esophageal cancer	0.000544	0.00799	CcSEcCtD
Daunorubicin—ABCC10—trachea—esophageal cancer	0.000538	0.0216	CbGeAlD
Daunorubicin—Haemorrhoids—Capecitabine—esophageal cancer	0.000537	0.00789	CcSEcCtD
Daunorubicin—Skin hyperpigmentation—Capecitabine—esophageal cancer	0.000531	0.0078	CcSEcCtD
Daunorubicin—Febrile neutropenia—Capecitabine—esophageal cancer	0.000525	0.00771	CcSEcCtD
Daunorubicin—Infection—Carboplatin—esophageal cancer	0.000518	0.00761	CcSEcCtD
Daunorubicin—Lung infiltration—Methotrexate—esophageal cancer	0.000501	0.00737	CcSEcCtD
Daunorubicin—Extravasation—Cisplatin—esophageal cancer	0.000491	0.00722	CcSEcCtD
Daunorubicin—POR—lung—esophageal cancer	0.000487	0.0196	CbGeAlD
Daunorubicin—Nail disorder—Capecitabine—esophageal cancer	0.000487	0.00715	CcSEcCtD
Daunorubicin—Supraventricular tachycardia—Capecitabine—esophageal cancer	0.000482	0.00708	CcSEcCtD
Daunorubicin—Cellulitis—Cisplatin—esophageal cancer	0.000471	0.00692	CcSEcCtD
Daunorubicin—Doxorubicin—ABCC2—esophageal cancer	0.000468	0.175	CrCbGaD
Daunorubicin—Bone marrow depression—Capecitabine—esophageal cancer	0.000468	0.00687	CcSEcCtD
Daunorubicin—ABCC10—digestive system—esophageal cancer	0.000463	0.0186	CbGeAlD
Daunorubicin—Hyperuricaemia—Cisplatin—esophageal cancer	0.000462	0.00679	CcSEcCtD
Daunorubicin—CYP1B1—smooth muscle tissue—esophageal cancer	0.000461	0.0185	CbGeAlD
Daunorubicin—TOP2A—lung—esophageal cancer	0.000454	0.0182	CbGeAlD
Daunorubicin—Ulcer—Cisplatin—esophageal cancer	0.000453	0.00666	CcSEcCtD
Daunorubicin—Hepatomegaly—Capecitabine—esophageal cancer	0.000446	0.00656	CcSEcCtD
Daunorubicin—Pain—Carboplatin—esophageal cancer	0.000446	0.00655	CcSEcCtD
Daunorubicin—YWHAG—lymph node—esophageal cancer	0.000438	0.0176	CbGeAlD
Daunorubicin—Blood uric acid increased—Cisplatin—esophageal cancer	0.000436	0.00641	CcSEcCtD
Daunorubicin—Hiccups—Cisplatin—esophageal cancer	0.000428	0.0063	CcSEcCtD
Daunorubicin—Haemoptysis—Capecitabine—esophageal cancer	0.000427	0.00627	CcSEcCtD
Daunorubicin—Mucosal inflammation—Methotrexate—esophageal cancer	0.000425	0.00624	CcSEcCtD
Daunorubicin—ABCC1—bronchus—esophageal cancer	0.000424	0.017	CbGeAlD
Daunorubicin—TOP2B—lymph node—esophageal cancer	0.000422	0.017	CbGeAlD
Daunorubicin—Body temperature increased—Carboplatin—esophageal cancer	0.000412	0.00605	CcSEcCtD
Daunorubicin—Neuropathy—Cisplatin—esophageal cancer	0.000402	0.00591	CcSEcCtD
Daunorubicin—Skin hyperpigmentation—Methotrexate—esophageal cancer	0.000395	0.00581	CcSEcCtD
Daunorubicin—Febrile neutropenia—Methotrexate—esophageal cancer	0.000391	0.00574	CcSEcCtD
Daunorubicin—Rigors—Capecitabine—esophageal cancer	0.000387	0.00568	CcSEcCtD
Daunorubicin—ABCC10—lung—esophageal cancer	0.000386	0.0155	CbGeAlD
Daunorubicin—ABCC1—trachea—esophageal cancer	0.00038	0.0153	CbGeAlD
Daunorubicin—Folliculitis—Methotrexate—esophageal cancer	0.000374	0.0055	CcSEcCtD
Daunorubicin—ABCC2—digestive system—esophageal cancer	0.000371	0.0149	CbGeAlD
Daunorubicin—CYP1B1—digestive system—esophageal cancer	0.000364	0.0146	CbGeAlD
Daunorubicin—Nail disorder—Methotrexate—esophageal cancer	0.000362	0.00533	CcSEcCtD
Daunorubicin—Chest discomfort—Capecitabine—esophageal cancer	0.000357	0.00524	CcSEcCtD
Daunorubicin—Polyuria—Cisplatin—esophageal cancer	0.000354	0.0052	CcSEcCtD
Daunorubicin—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.00035	0.00514	CcSEcCtD
Daunorubicin—Bone marrow depression—Methotrexate—esophageal cancer	0.000348	0.00512	CcSEcCtD
Daunorubicin—Deafness—Cisplatin—esophageal cancer	0.000348	0.00511	CcSEcCtD
Daunorubicin—Cellulitis—Capecitabine—esophageal cancer	0.000347	0.0051	CcSEcCtD
Daunorubicin—Liver disorder—Methotrexate—esophageal cancer	0.000345	0.00507	CcSEcCtD
Daunorubicin—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000343	0.00504	CcSEcCtD
Daunorubicin—Nocturia—Capecitabine—esophageal cancer	0.00034	0.005	CcSEcCtD
Daunorubicin—CYP1A1—epithelium—esophageal cancer	0.000338	0.0136	CbGeAlD
Daunorubicin—Ulcer—Capecitabine—esophageal cancer	0.000334	0.00491	CcSEcCtD
Daunorubicin—POR—lymph node—esophageal cancer	0.000333	0.0134	CbGeAlD
Daunorubicin—CYP1A1—bronchus—esophageal cancer	0.000333	0.0134	CbGeAlD
Daunorubicin—Amnesia—Cisplatin—esophageal cancer	0.000331	0.00486	CcSEcCtD
Daunorubicin—Gait disturbance—Capecitabine—esophageal cancer	0.000324	0.00475	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000321	0.00472	CcSEcCtD
Daunorubicin—Hiccups—Capecitabine—esophageal cancer	0.000316	0.00464	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000311	0.00457	CcSEcCtD
Daunorubicin—TOP2A—lymph node—esophageal cancer	0.00031	0.0125	CbGeAlD
Daunorubicin—Melaena—Capecitabine—esophageal cancer	0.000308	0.00453	CcSEcCtD
Daunorubicin—Influenza like illness—Capecitabine—esophageal cancer	0.000307	0.00451	CcSEcCtD
Daunorubicin—CYP1B1—lung—esophageal cancer	0.000304	0.0122	CbGeAlD
Daunorubicin—Necrosis—Methotrexate—esophageal cancer	0.0003	0.0044	CcSEcCtD
Daunorubicin—CYP1A1—trachea—esophageal cancer	0.000299	0.012	CbGeAlD
Daunorubicin—Neuropathy—Capecitabine—esophageal cancer	0.000297	0.00436	CcSEcCtD
Daunorubicin—Dehydration—Cisplatin—esophageal cancer	0.000289	0.00425	CcSEcCtD
Daunorubicin—Oesophagitis—Capecitabine—esophageal cancer	0.000289	0.00424	CcSEcCtD
Daunorubicin—Urine output increased—Capecitabine—esophageal cancer	0.000286	0.0042	CcSEcCtD
Daunorubicin—Abnormal vision—Capecitabine—esophageal cancer	0.000275	0.00405	CcSEcCtD
Daunorubicin—Mental disability—Capecitabine—esophageal cancer	0.000274	0.00403	CcSEcCtD
Daunorubicin—ABCC1—lung—esophageal cancer	0.000273	0.011	CbGeAlD
Daunorubicin—Extravasation—Methotrexate—esophageal cancer	0.000269	0.00396	CcSEcCtD
Daunorubicin—Ear pain—Capecitabine—esophageal cancer	0.000269	0.00395	CcSEcCtD
Daunorubicin—Thrombophlebitis—Capecitabine—esophageal cancer	0.000265	0.00389	CcSEcCtD
Daunorubicin—ABCC10—lymph node—esophageal cancer	0.000264	0.0106	CbGeAlD
Daunorubicin—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000262	0.00385	CcSEcCtD
Daunorubicin—Sweating increased—Cisplatin—esophageal cancer	0.000262	0.00385	CcSEcCtD
Daunorubicin—Polyuria—Capecitabine—esophageal cancer	0.000261	0.00384	CcSEcCtD
Daunorubicin—CYP1A2—digestive system—esophageal cancer	0.000261	0.0105	CbGeAlD
Daunorubicin—CYP1A1—digestive system—esophageal cancer	0.000257	0.0103	CbGeAlD
Daunorubicin—Deafness—Capecitabine—esophageal cancer	0.000256	0.00377	CcSEcCtD
Daunorubicin—Pancytopenia—Cisplatin—esophageal cancer	0.000255	0.00375	CcSEcCtD
Daunorubicin—Eye pain—Capecitabine—esophageal cancer	0.000254	0.00373	CcSEcCtD
Daunorubicin—Hyperuricaemia—Methotrexate—esophageal cancer	0.000253	0.00372	CcSEcCtD
Daunorubicin—CYP3A5—digestive system—esophageal cancer	0.000251	0.0101	CbGeAlD
Daunorubicin—Ulcer—Methotrexate—esophageal cancer	0.000249	0.00365	CcSEcCtD
Daunorubicin—Hot flush—Capecitabine—esophageal cancer	0.000245	0.0036	CcSEcCtD
Daunorubicin—Increased appetite—Capecitabine—esophageal cancer	0.000244	0.00359	CcSEcCtD
Daunorubicin—Amnesia—Capecitabine—esophageal cancer	0.000244	0.00359	CcSEcCtD
Daunorubicin—Menopausal symptoms—Capecitabine—esophageal cancer	0.000243	0.00357	CcSEcCtD
Daunorubicin—Atrial fibrillation—Capecitabine—esophageal cancer	0.000242	0.00355	CcSEcCtD
Daunorubicin—Renal impairment—Capecitabine—esophageal cancer	0.000241	0.00354	CcSEcCtD
Daunorubicin—Thirst—Capecitabine—esophageal cancer	0.000241	0.00354	CcSEcCtD
Daunorubicin—Blood uric acid increased—Methotrexate—esophageal cancer	0.000239	0.00352	CcSEcCtD
Daunorubicin—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000236	0.00347	CcSEcCtD
Daunorubicin—Renal failure—Cisplatin—esophageal cancer	0.000236	0.00346	CcSEcCtD
Daunorubicin—Myocardial infarction—Cisplatin—esophageal cancer	0.000235	0.00345	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000235	0.00345	CcSEcCtD
Daunorubicin—Cardiac failure—Capecitabine—esophageal cancer	0.000235	0.00345	CcSEcCtD
Daunorubicin—Stomatitis—Cisplatin—esophageal cancer	0.000234	0.00343	CcSEcCtD
Daunorubicin—Conjunctivitis—Cisplatin—esophageal cancer	0.000233	0.00342	CcSEcCtD
Daunorubicin—Melaena—Methotrexate—esophageal cancer	0.00023	0.00337	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000229	0.00337	CcSEcCtD
Daunorubicin—ABCG2—lung—esophageal cancer	0.000226	0.00909	CbGeAlD
Daunorubicin—Cardiac arrest—Capecitabine—esophageal cancer	0.000218	0.0032	CcSEcCtD
Daunorubicin—CYP1A2—lung—esophageal cancer	0.000218	0.00875	CbGeAlD
Daunorubicin—Mood swings—Capecitabine—esophageal cancer	0.000217	0.00319	CcSEcCtD
Daunorubicin—Ataxia—Capecitabine—esophageal cancer	0.000216	0.00317	CcSEcCtD
Daunorubicin—CYP1A1—lung—esophageal cancer	0.000215	0.00863	CbGeAlD
Daunorubicin—Dehydration—Capecitabine—esophageal cancer	0.000213	0.00313	CcSEcCtD
Daunorubicin—Urine output increased—Methotrexate—esophageal cancer	0.000213	0.00312	CcSEcCtD
Daunorubicin—ABCC2—lymph node—esophageal cancer	0.000212	0.00853	CbGeAlD
Daunorubicin—Dry skin—Capecitabine—esophageal cancer	0.00021	0.00309	CcSEcCtD
Daunorubicin—CYP3A5—lung—esophageal cancer	0.00021	0.00844	CbGeAlD
Daunorubicin—CYP1B1—lymph node—esophageal cancer	0.000208	0.00835	CbGeAlD
Daunorubicin—Visual impairment—Cisplatin—esophageal cancer	0.000207	0.00305	CcSEcCtD
Daunorubicin—Gastritis—Capecitabine—esophageal cancer	0.000203	0.00298	CcSEcCtD
Daunorubicin—Tinnitus—Cisplatin—esophageal cancer	0.000201	0.00295	CcSEcCtD
Daunorubicin—Lymphadenopathy—Methotrexate—esophageal cancer	0.0002	0.00294	CcSEcCtD
Daunorubicin—Flushing—Cisplatin—esophageal cancer	0.0002	0.00293	CcSEcCtD
Daunorubicin—Cardiac disorder—Cisplatin—esophageal cancer	0.0002	0.00293	CcSEcCtD
Daunorubicin—Dysphagia—Capecitabine—esophageal cancer	0.000198	0.00291	CcSEcCtD
Daunorubicin—Thrombophlebitis—Methotrexate—esophageal cancer	0.000197	0.0029	CcSEcCtD
Daunorubicin—Polyuria—Methotrexate—esophageal cancer	0.000194	0.00286	CcSEcCtD
Daunorubicin—Sweating increased—Capecitabine—esophageal cancer	0.000193	0.00284	CcSEcCtD
Daunorubicin—Angina pectoris—Capecitabine—esophageal cancer	0.000193	0.00284	CcSEcCtD
Daunorubicin—Arrhythmia—Cisplatin—esophageal cancer	0.000192	0.00282	CcSEcCtD
Daunorubicin—Alopecia—Cisplatin—esophageal cancer	0.00019	0.00279	CcSEcCtD
Daunorubicin—CYP3A4—digestive system—esophageal cancer	0.000189	0.00758	CbGeAlD
Daunorubicin—Pancytopenia—Capecitabine—esophageal cancer	0.000188	0.00276	CcSEcCtD
Daunorubicin—Erythema—Cisplatin—esophageal cancer	0.000187	0.00275	CcSEcCtD
Daunorubicin—ABCC1—lymph node—esophageal cancer	0.000187	0.00751	CbGeAlD
Daunorubicin—Neutropenia—Capecitabine—esophageal cancer	0.000185	0.00272	CcSEcCtD
Daunorubicin—Dysuria—Capecitabine—esophageal cancer	0.000185	0.00272	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000176	0.00259	CcSEcCtD
Daunorubicin—Depression—Capecitabine—esophageal cancer	0.000176	0.00259	CcSEcCtD
Daunorubicin—ABCB1—epithelium—esophageal cancer	0.000176	0.00706	CbGeAlD
Daunorubicin—Tremor—Cisplatin—esophageal cancer	0.000175	0.00258	CcSEcCtD
Daunorubicin—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000174	0.00256	CcSEcCtD
Daunorubicin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000174	0.00255	CcSEcCtD
Daunorubicin—Renal failure—Capecitabine—esophageal cancer	0.000174	0.00255	CcSEcCtD
Daunorubicin—Myocardial infarction—Capecitabine—esophageal cancer	0.000173	0.00254	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000173	0.00254	CcSEcCtD
Daunorubicin—Anaemia—Cisplatin—esophageal cancer	0.000173	0.00254	CcSEcCtD
Daunorubicin—Stomatitis—Capecitabine—esophageal cancer	0.000172	0.00253	CcSEcCtD
Daunorubicin—Doxorubicin—ABCB1—esophageal cancer	0.000172	0.0643	CrCbGaD
Daunorubicin—Conjunctivitis—Capecitabine—esophageal cancer	0.000172	0.00252	CcSEcCtD
Daunorubicin—Malaise—Cisplatin—esophageal cancer	0.000169	0.00248	CcSEcCtD
Daunorubicin—Leukopenia—Cisplatin—esophageal cancer	0.000168	0.00246	CcSEcCtD
Daunorubicin—Convulsion—Cisplatin—esophageal cancer	0.000162	0.00238	CcSEcCtD
Daunorubicin—Mood swings—Methotrexate—esophageal cancer	0.000162	0.00238	CcSEcCtD
Daunorubicin—Ataxia—Methotrexate—esophageal cancer	0.00016	0.00236	CcSEcCtD
Daunorubicin—Myalgia—Cisplatin—esophageal cancer	0.000159	0.00234	CcSEcCtD
Daunorubicin—Rhinitis—Capecitabine—esophageal cancer	0.000159	0.00234	CcSEcCtD
Daunorubicin—Anxiety—Cisplatin—esophageal cancer	0.000159	0.00233	CcSEcCtD
Daunorubicin—Discomfort—Cisplatin—esophageal cancer	0.000158	0.00231	CcSEcCtD
Daunorubicin—ABCB1—trachea—esophageal cancer	0.000155	0.00624	CbGeAlD
Daunorubicin—ABCG2—lymph node—esophageal cancer	0.000155	0.00622	CbGeAlD
Daunorubicin—Oedema—Cisplatin—esophageal cancer	0.000153	0.00225	CcSEcCtD
Daunorubicin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000153	0.00225	CcSEcCtD
Daunorubicin—Visual impairment—Capecitabine—esophageal cancer	0.000153	0.00225	CcSEcCtD
Daunorubicin—Infection—Cisplatin—esophageal cancer	0.000152	0.00223	CcSEcCtD
Daunorubicin—Thrombocytopenia—Cisplatin—esophageal cancer	0.00015	0.0022	CcSEcCtD
Daunorubicin—Tachycardia—Cisplatin—esophageal cancer	0.000149	0.00219	CcSEcCtD
Daunorubicin—Tinnitus—Capecitabine—esophageal cancer	0.000148	0.00217	CcSEcCtD
Daunorubicin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000148	0.00217	CcSEcCtD
Daunorubicin—Flushing—Capecitabine—esophageal cancer	0.000147	0.00216	CcSEcCtD
Daunorubicin—Cardiac disorder—Capecitabine—esophageal cancer	0.000147	0.00216	CcSEcCtD
Daunorubicin—CYP1A1—lymph node—esophageal cancer	0.000147	0.0059	CbGeAlD
Daunorubicin—Anorexia—Cisplatin—esophageal cancer	0.000146	0.00214	CcSEcCtD
Daunorubicin—Chills—Capecitabine—esophageal cancer	0.000142	0.00209	CcSEcCtD
Daunorubicin—Arrhythmia—Capecitabine—esophageal cancer	0.000142	0.00208	CcSEcCtD
Daunorubicin—Alopecia—Capecitabine—esophageal cancer	0.00014	0.00206	CcSEcCtD
Daunorubicin—Pancytopenia—Methotrexate—esophageal cancer	0.00014	0.00206	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000139	0.00205	CcSEcCtD
Daunorubicin—Erythema—Capecitabine—esophageal cancer	0.000138	0.00203	CcSEcCtD
Daunorubicin—Dysuria—Methotrexate—esophageal cancer	0.000138	0.00203	CcSEcCtD
Daunorubicin—Neutropenia—Methotrexate—esophageal cancer	0.000138	0.00203	CcSEcCtD
Daunorubicin—Dyspnoea—Cisplatin—esophageal cancer	0.000136	0.002	CcSEcCtD
Daunorubicin—Dysgeusia—Capecitabine—esophageal cancer	0.000135	0.00199	CcSEcCtD
Daunorubicin—ABCB1—digestive system—esophageal cancer	0.000134	0.00537	CbGeAlD
Daunorubicin—Back pain—Capecitabine—esophageal cancer	0.000134	0.00196	CcSEcCtD
Daunorubicin—Decreased appetite—Cisplatin—esophageal cancer	0.000133	0.00195	CcSEcCtD
Daunorubicin—Depression—Methotrexate—esophageal cancer	0.000131	0.00193	CcSEcCtD
Daunorubicin—Pain—Cisplatin—esophageal cancer	0.000131	0.00192	CcSEcCtD
Daunorubicin—Tremor—Capecitabine—esophageal cancer	0.000129	0.0019	CcSEcCtD
Daunorubicin—Renal failure—Methotrexate—esophageal cancer	0.000129	0.0019	CcSEcCtD
Daunorubicin—Stomatitis—Methotrexate—esophageal cancer	0.000128	0.00188	CcSEcCtD
Daunorubicin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000128	0.00188	CcSEcCtD
Daunorubicin—Conjunctivitis—Methotrexate—esophageal cancer	0.000128	0.00188	CcSEcCtD
Daunorubicin—Anaemia—Capecitabine—esophageal cancer	0.000128	0.00188	CcSEcCtD
Daunorubicin—Feeling abnormal—Cisplatin—esophageal cancer	0.000126	0.00185	CcSEcCtD
Daunorubicin—Malaise—Capecitabine—esophageal cancer	0.000124	0.00183	CcSEcCtD
Daunorubicin—Syncope—Capecitabine—esophageal cancer	0.000124	0.00182	CcSEcCtD
Daunorubicin—Leukopenia—Capecitabine—esophageal cancer	0.000124	0.00182	CcSEcCtD
Daunorubicin—Palpitations—Capecitabine—esophageal cancer	0.000122	0.00179	CcSEcCtD
Daunorubicin—Loss of consciousness—Capecitabine—esophageal cancer	0.000121	0.00178	CcSEcCtD
Daunorubicin—Body temperature increased—Cisplatin—esophageal cancer	0.000121	0.00178	CcSEcCtD
Daunorubicin—Cough—Capecitabine—esophageal cancer	0.00012	0.00177	CcSEcCtD
Daunorubicin—Hypertension—Capecitabine—esophageal cancer	0.000119	0.00175	CcSEcCtD
Daunorubicin—Arthralgia—Capecitabine—esophageal cancer	0.000118	0.00173	CcSEcCtD
Daunorubicin—Chest pain—Capecitabine—esophageal cancer	0.000118	0.00173	CcSEcCtD
Daunorubicin—Myalgia—Capecitabine—esophageal cancer	0.000118	0.00173	CcSEcCtD
Daunorubicin—Anxiety—Capecitabine—esophageal cancer	0.000117	0.00172	CcSEcCtD
Daunorubicin—Discomfort—Capecitabine—esophageal cancer	0.000116	0.00171	CcSEcCtD
Daunorubicin—Dry mouth—Capecitabine—esophageal cancer	0.000115	0.00169	CcSEcCtD
Daunorubicin—Visual impairment—Methotrexate—esophageal cancer	0.000114	0.00167	CcSEcCtD
Daunorubicin—Confusional state—Capecitabine—esophageal cancer	0.000114	0.00167	CcSEcCtD
Daunorubicin—Oedema—Capecitabine—esophageal cancer	0.000113	0.00166	CcSEcCtD
Daunorubicin—Hypersensitivity—Cisplatin—esophageal cancer	0.000113	0.00165	CcSEcCtD
Daunorubicin—Infection—Capecitabine—esophageal cancer	0.000112	0.00164	CcSEcCtD
Daunorubicin—ABCB1—lung—esophageal cancer	0.000112	0.00448	CbGeAlD
Daunorubicin—Shock—Capecitabine—esophageal cancer	0.000111	0.00163	CcSEcCtD
Daunorubicin—Thrombocytopenia—Capecitabine—esophageal cancer	0.00011	0.00162	CcSEcCtD
Daunorubicin—Tinnitus—Methotrexate—esophageal cancer	0.00011	0.00162	CcSEcCtD
Daunorubicin—Tachycardia—Capecitabine—esophageal cancer	0.00011	0.00162	CcSEcCtD
Daunorubicin—Asthenia—Cisplatin—esophageal cancer	0.00011	0.00161	CcSEcCtD
Daunorubicin—Cardiac disorder—Methotrexate—esophageal cancer	0.00011	0.00161	CcSEcCtD
Daunorubicin—Hyperhidrosis—Capecitabine—esophageal cancer	0.000109	0.0016	CcSEcCtD
Daunorubicin—Anorexia—Capecitabine—esophageal cancer	0.000107	0.00158	CcSEcCtD
Daunorubicin—Chills—Methotrexate—esophageal cancer	0.000106	0.00156	CcSEcCtD
Daunorubicin—Diarrhoea—Cisplatin—esophageal cancer	0.000105	0.00154	CcSEcCtD
Daunorubicin—Alopecia—Methotrexate—esophageal cancer	0.000104	0.00153	CcSEcCtD
Daunorubicin—Erythema—Methotrexate—esophageal cancer	0.000103	0.00151	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000103	0.00151	CcSEcCtD
Daunorubicin—Insomnia—Capecitabine—esophageal cancer	0.000102	0.0015	CcSEcCtD
Daunorubicin—Dysgeusia—Methotrexate—esophageal cancer	0.000101	0.00148	CcSEcCtD
Daunorubicin—Dyspnoea—Capecitabine—esophageal cancer	0.0001	0.00148	CcSEcCtD
Daunorubicin—Back pain—Methotrexate—esophageal cancer	9.94e-05	0.00146	CcSEcCtD
Daunorubicin—Decreased appetite—Capecitabine—esophageal cancer	9.79e-05	0.00144	CcSEcCtD
Daunorubicin—Vomiting—Cisplatin—esophageal cancer	9.72e-05	0.00143	CcSEcCtD
Daunorubicin—Fatigue—Capecitabine—esophageal cancer	9.71e-05	0.00143	CcSEcCtD
Daunorubicin—Rash—Cisplatin—esophageal cancer	9.64e-05	0.00142	CcSEcCtD
Daunorubicin—Pain—Capecitabine—esophageal cancer	9.64e-05	0.00142	CcSEcCtD
Daunorubicin—Constipation—Capecitabine—esophageal cancer	9.64e-05	0.00142	CcSEcCtD
Daunorubicin—Dermatitis—Cisplatin—esophageal cancer	9.63e-05	0.00141	CcSEcCtD
Daunorubicin—Ill-defined disorder—Methotrexate—esophageal cancer	9.54e-05	0.0014	CcSEcCtD
Daunorubicin—Anaemia—Methotrexate—esophageal cancer	9.5e-05	0.0014	CcSEcCtD
Daunorubicin—Feeling abnormal—Capecitabine—esophageal cancer	9.28e-05	0.00136	CcSEcCtD
Daunorubicin—Malaise—Methotrexate—esophageal cancer	9.27e-05	0.00136	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Capecitabine—esophageal cancer	9.21e-05	0.00135	CcSEcCtD
Daunorubicin—Leukopenia—Methotrexate—esophageal cancer	9.2e-05	0.00135	CcSEcCtD
Daunorubicin—Nausea—Cisplatin—esophageal cancer	9.08e-05	0.00133	CcSEcCtD
Daunorubicin—Cough—Methotrexate—esophageal cancer	8.97e-05	0.00132	CcSEcCtD
Daunorubicin—Urticaria—Capecitabine—esophageal cancer	8.95e-05	0.00132	CcSEcCtD
Daunorubicin—Abdominal pain—Capecitabine—esophageal cancer	8.91e-05	0.00131	CcSEcCtD
Daunorubicin—Body temperature increased—Capecitabine—esophageal cancer	8.91e-05	0.00131	CcSEcCtD
Daunorubicin—Convulsion—Methotrexate—esophageal cancer	8.9e-05	0.00131	CcSEcCtD
Daunorubicin—Chest pain—Methotrexate—esophageal cancer	8.75e-05	0.00129	CcSEcCtD
Daunorubicin—Myalgia—Methotrexate—esophageal cancer	8.75e-05	0.00129	CcSEcCtD
Daunorubicin—Arthralgia—Methotrexate—esophageal cancer	8.75e-05	0.00129	CcSEcCtD
Daunorubicin—Discomfort—Methotrexate—esophageal cancer	8.64e-05	0.00127	CcSEcCtD
Daunorubicin—Confusional state—Methotrexate—esophageal cancer	8.46e-05	0.00124	CcSEcCtD
Daunorubicin—Anaphylactic shock—Methotrexate—esophageal cancer	8.39e-05	0.00123	CcSEcCtD
Daunorubicin—Infection—Methotrexate—esophageal cancer	8.33e-05	0.00122	CcSEcCtD
Daunorubicin—Hypersensitivity—Capecitabine—esophageal cancer	8.3e-05	0.00122	CcSEcCtD
Daunorubicin—Thrombocytopenia—Methotrexate—esophageal cancer	8.21e-05	0.00121	CcSEcCtD
Daunorubicin—Hyperhidrosis—Methotrexate—esophageal cancer	8.11e-05	0.00119	CcSEcCtD
Daunorubicin—Asthenia—Capecitabine—esophageal cancer	8.08e-05	0.00119	CcSEcCtD
Daunorubicin—Anorexia—Methotrexate—esophageal cancer	8e-05	0.00117	CcSEcCtD
Daunorubicin—Pruritus—Capecitabine—esophageal cancer	7.97e-05	0.00117	CcSEcCtD
Daunorubicin—Diarrhoea—Capecitabine—esophageal cancer	7.71e-05	0.00113	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	7.64e-05	0.00112	CcSEcCtD
Daunorubicin—ABCB1—lymph node—esophageal cancer	7.63e-05	0.00307	CbGeAlD
Daunorubicin—Insomnia—Methotrexate—esophageal cancer	7.59e-05	0.00111	CcSEcCtD
Daunorubicin—Dyspnoea—Methotrexate—esophageal cancer	7.48e-05	0.0011	CcSEcCtD
Daunorubicin—Somnolence—Methotrexate—esophageal cancer	7.46e-05	0.0011	CcSEcCtD
Daunorubicin—Dizziness—Capecitabine—esophageal cancer	7.45e-05	0.00109	CcSEcCtD
Daunorubicin—Decreased appetite—Methotrexate—esophageal cancer	7.29e-05	0.00107	CcSEcCtD
Daunorubicin—Fatigue—Methotrexate—esophageal cancer	7.23e-05	0.00106	CcSEcCtD
Daunorubicin—Pain—Methotrexate—esophageal cancer	7.17e-05	0.00105	CcSEcCtD
Daunorubicin—Vomiting—Capecitabine—esophageal cancer	7.16e-05	0.00105	CcSEcCtD
Daunorubicin—Rash—Capecitabine—esophageal cancer	7.1e-05	0.00104	CcSEcCtD
Daunorubicin—Dermatitis—Capecitabine—esophageal cancer	7.1e-05	0.00104	CcSEcCtD
Daunorubicin—Headache—Capecitabine—esophageal cancer	7.06e-05	0.00104	CcSEcCtD
Daunorubicin—Feeling abnormal—Methotrexate—esophageal cancer	6.91e-05	0.00102	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Methotrexate—esophageal cancer	6.86e-05	0.00101	CcSEcCtD
Daunorubicin—Nausea—Capecitabine—esophageal cancer	6.69e-05	0.000983	CcSEcCtD
Daunorubicin—Urticaria—Methotrexate—esophageal cancer	6.66e-05	0.000979	CcSEcCtD
Daunorubicin—Body temperature increased—Methotrexate—esophageal cancer	6.63e-05	0.000974	CcSEcCtD
Daunorubicin—Abdominal pain—Methotrexate—esophageal cancer	6.63e-05	0.000974	CcSEcCtD
Daunorubicin—Hypersensitivity—Methotrexate—esophageal cancer	6.18e-05	0.000908	CcSEcCtD
Daunorubicin—Asthenia—Methotrexate—esophageal cancer	6.02e-05	0.000884	CcSEcCtD
Daunorubicin—Pruritus—Methotrexate—esophageal cancer	5.93e-05	0.000872	CcSEcCtD
Daunorubicin—Diarrhoea—Methotrexate—esophageal cancer	5.74e-05	0.000843	CcSEcCtD
Daunorubicin—Dizziness—Methotrexate—esophageal cancer	5.55e-05	0.000815	CcSEcCtD
Daunorubicin—Vomiting—Methotrexate—esophageal cancer	5.33e-05	0.000784	CcSEcCtD
Daunorubicin—Rash—Methotrexate—esophageal cancer	5.29e-05	0.000777	CcSEcCtD
Daunorubicin—Dermatitis—Methotrexate—esophageal cancer	5.28e-05	0.000776	CcSEcCtD
Daunorubicin—Headache—Methotrexate—esophageal cancer	5.25e-05	0.000772	CcSEcCtD
Daunorubicin—Nausea—Methotrexate—esophageal cancer	4.98e-05	0.000732	CcSEcCtD
Daunorubicin—CYP1A2—Metabolism—SLC52A3—esophageal cancer	8.35e-06	9.41e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—BLVRB—esophageal cancer	8.35e-06	9.41e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PSME1—esophageal cancer	8.35e-06	9.4e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PSME2—esophageal cancer	8.35e-06	9.4e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.34e-06	9.4e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ADH1B—esophageal cancer	8.31e-06	9.36e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GSTT1—esophageal cancer	8.22e-06	9.26e-05	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MYC—esophageal cancer	8.18e-06	9.21e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP26A1—esophageal cancer	8.17e-06	9.21e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ABCB1—esophageal cancer	8.16e-06	9.19e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CA2—esophageal cancer	8.14e-06	9.17e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GSTT1—esophageal cancer	8.14e-06	9.17e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP2A6—esophageal cancer	8.13e-06	9.16e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP2A6—esophageal cancer	8.05e-06	9.06e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ALOX15—esophageal cancer	7.97e-06	8.97e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TYMP—esophageal cancer	7.94e-06	8.94e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	7.76e-06	8.74e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TGFBR2—esophageal cancer	7.74e-06	8.71e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP26A1—esophageal cancer	7.72e-06	8.7e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS1—esophageal cancer	7.71e-06	8.68e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ENO1—esophageal cancer	7.71e-06	8.68e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.7e-06	8.67e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ENO1—esophageal cancer	7.63e-06	8.59e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS1—esophageal cancer	7.63e-06	8.59e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.62e-06	8.58e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TPI1—esophageal cancer	7.6e-06	8.56e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTO1—esophageal cancer	7.6e-06	8.56e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PSME2—esophageal cancer	7.59e-06	8.55e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PSME1—esophageal cancer	7.59e-06	8.55e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PLCE1—esophageal cancer	7.57e-06	8.52e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ADH7—esophageal cancer	7.57e-06	8.52e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.54e-06	8.49e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ALOX15—esophageal cancer	7.53e-06	8.48e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PSME2—esophageal cancer	7.52e-06	8.46e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PSME1—esophageal cancer	7.52e-06	8.46e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	7.5e-06	8.45e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	7.47e-06	8.41e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP1B1—esophageal cancer	7.45e-06	8.39e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—CREBBP—esophageal cancer	7.4e-06	8.34e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SMAD4—esophageal cancer	7.32e-06	8.25e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.29e-06	8.21e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ALDOB—esophageal cancer	7.29e-06	8.21e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTO1—esophageal cancer	7.18e-06	8.09e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TPI1—esophageal cancer	7.18e-06	8.09e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	7.14e-06	8.04e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CA1—esophageal cancer	7.1e-06	8e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC10A2—esophageal cancer	7.1e-06	8e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GAPDH—esophageal cancer	7.01e-06	7.9e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP19A1—esophageal cancer	7e-06	7.89e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CRABP1—esophageal cancer	6.95e-06	7.83e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ALDOB—esophageal cancer	6.88e-06	7.75e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP19A1—esophageal cancer	6.77e-06	7.63e-05	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—esophageal cancer	6.72e-06	7.57e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ADH1B—esophageal cancer	6.63e-06	7.47e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GAPDH—esophageal cancer	6.63e-06	7.46e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—NOS3—esophageal cancer	6.63e-06	7.46e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GNG7—esophageal cancer	6.61e-06	7.45e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CRABP1—esophageal cancer	6.57e-06	7.4e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP1B1—esophageal cancer	6.55e-06	7.38e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CA2—esophageal cancer	6.5e-06	7.32e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.49e-06	7.31e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP1B1—esophageal cancer	6.48e-06	7.3e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—BLVRB—esophageal cancer	6.45e-06	7.26e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	6.45e-06	7.26e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—HMOX1—esophageal cancer	6.39e-06	7.2e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6.35e-06	7.15e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TYMP—esophageal cancer	6.34e-06	7.14e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.27e-06	7.06e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GNG7—esophageal cancer	6.25e-06	7.04e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	6.22e-06	7.01e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ALDH2—esophageal cancer	6.19e-06	6.98e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—HMOX1—esophageal cancer	6.18e-06	6.96e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.17e-06	6.95e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP26A1—esophageal cancer	6.17e-06	6.95e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP19A1—esophageal cancer	6.16e-06	6.94e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ABCB1—esophageal cancer	6.13e-06	6.91e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP19A1—esophageal cancer	6.1e-06	6.87e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	6.09e-06	6.86e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.06e-06	6.83e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTGS2—esophageal cancer	6.06e-06	6.83e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PLCE1—esophageal cancer	6.04e-06	6.8e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ADH7—esophageal cancer	6.04e-06	6.8e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALOX15—esophageal cancer	6.01e-06	6.77e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HIF1A—esophageal cancer	5.99e-06	6.75e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.97e-06	6.73e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ABCB1—esophageal cancer	5.93e-06	6.68e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTT1—esophageal cancer	5.89e-06	6.64e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ALDH2—esophageal cancer	5.85e-06	6.59e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP2A6—esophageal cancer	5.82e-06	6.56e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TPI1—esophageal cancer	5.73e-06	6.46e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTO1—esophageal cancer	5.73e-06	6.46e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—HMOX1—esophageal cancer	5.62e-06	6.33e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTT1—esophageal cancer	5.57e-06	6.27e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—HMOX1—esophageal cancer	5.56e-06	6.27e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS1—esophageal cancer	5.52e-06	6.22e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ENO1—esophageal cancer	5.52e-06	6.22e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP2A6—esophageal cancer	5.5e-06	6.2e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALDOB—esophageal cancer	5.5e-06	6.19e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	5.48e-06	6.18e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CA1—esophageal cancer	5.48e-06	6.18e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.48e-06	6.17e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CREBBP—esophageal cancer	5.46e-06	6.15e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NOS2—esophageal cancer	5.45e-06	6.14e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PSME1—esophageal cancer	5.44e-06	6.13e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PSME2—esophageal cancer	5.44e-06	6.13e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NOTCH1—esophageal cancer	5.4e-06	6.08e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ABCB1—esophageal cancer	5.4e-06	6.08e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ABCB1—esophageal cancer	5.34e-06	6.02e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ADH1B—esophageal cancer	5.3e-06	5.97e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GAPDH—esophageal cancer	5.29e-06	5.96e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	5.28e-06	5.95e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CRABP1—esophageal cancer	5.24e-06	5.91e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ENO1—esophageal cancer	5.22e-06	5.88e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS1—esophageal cancer	5.22e-06	5.88e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PSME1—esophageal cancer	5.14e-06	5.79e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PSME2—esophageal cancer	5.14e-06	5.79e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	5.11e-06	5.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TYMP—esophageal cancer	5.06e-06	5.7e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—EP300—esophageal cancer	5.04e-06	5.68e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CA2—esophageal cancer	5.01e-06	5.65e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GNG7—esophageal cancer	4.99e-06	5.62e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP26A1—esophageal cancer	4.92e-06	5.55e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CREBBP—esophageal cancer	4.89e-06	5.51e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—NOS3—esophageal cancer	4.88e-06	5.5e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALOX15—esophageal cancer	4.8e-06	5.41e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP1B1—esophageal cancer	4.69e-06	5.29e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALDH2—esophageal cancer	4.67e-06	5.27e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ADH7—esophageal cancer	4.66e-06	5.25e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PLCE1—esophageal cancer	4.66e-06	5.25e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.64e-06	5.22e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTO1—esophageal cancer	4.58e-06	5.16e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TPI1—esophageal cancer	4.58e-06	5.16e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.49e-06	5.06e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.48e-06	5.05e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTGS2—esophageal cancer	4.47e-06	5.03e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTT1—esophageal cancer	4.45e-06	5.01e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP1B1—esophageal cancer	4.44e-06	5e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP19A1—esophageal cancer	4.41e-06	4.97e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP2A6—esophageal cancer	4.4e-06	4.95e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALDOB—esophageal cancer	4.39e-06	4.94e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NOS3—esophageal cancer	4.38e-06	4.94e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GAPDH—esophageal cancer	4.22e-06	4.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CRABP1—esophageal cancer	4.19e-06	4.72e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP19A1—esophageal cancer	4.17e-06	4.7e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS1—esophageal cancer	4.17e-06	4.69e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ENO1—esophageal cancer	4.17e-06	4.69e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.16e-06	4.69e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PSME1—esophageal cancer	4.11e-06	4.62e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PSME2—esophageal cancer	4.11e-06	4.62e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CREBBP—esophageal cancer	4.1e-06	4.62e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—ERBB2—esophageal cancer	4.1e-06	4.62e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ADH1B—esophageal cancer	4.09e-06	4.6e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—HMOX1—esophageal cancer	4.03e-06	4.54e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTGS2—esophageal cancer	4.01e-06	4.51e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GNG7—esophageal cancer	3.98e-06	4.49e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CREBBP—esophageal cancer	3.96e-06	4.46e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TYMP—esophageal cancer	3.91e-06	4.4e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ABCB1—esophageal cancer	3.87e-06	4.35e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—HMOX1—esophageal cancer	3.81e-06	4.29e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	3.8e-06	4.28e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.73e-06	4.21e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALDH2—esophageal cancer	3.73e-06	4.2e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CA—esophageal cancer	3.73e-06	4.2e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—EP300—esophageal cancer	3.72e-06	4.19e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALOX15—esophageal cancer	3.7e-06	4.17e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—NOS3—esophageal cancer	3.67e-06	4.13e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ABCB1—esophageal cancer	3.65e-06	4.11e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CREBBP—esophageal cancer	3.61e-06	4.06e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CREBBP—esophageal cancer	3.57e-06	4.02e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTT1—esophageal cancer	3.55e-06	4e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—NOS3—esophageal cancer	3.55e-06	4e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP1B1—esophageal cancer	3.54e-06	3.99e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TPI1—esophageal cancer	3.53e-06	3.98e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTO1—esophageal cancer	3.53e-06	3.98e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP2A6—esophageal cancer	3.51e-06	3.95e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN1A—esophageal cancer	3.5e-06	3.95e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.5e-06	3.94e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALDOB—esophageal cancer	3.39e-06	3.82e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTGS2—esophageal cancer	3.36e-06	3.78e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EP300—esophageal cancer	3.33e-06	3.75e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP19A1—esophageal cancer	3.33e-06	3.75e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ENO1—esophageal cancer	3.33e-06	3.75e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS1—esophageal cancer	3.33e-06	3.75e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PSME2—esophageal cancer	3.28e-06	3.69e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PSME1—esophageal cancer	3.28e-06	3.69e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GAPDH—esophageal cancer	3.26e-06	3.67e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTGS2—esophageal cancer	3.25e-06	3.66e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CRABP1—esophageal cancer	3.23e-06	3.64e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—NOS3—esophageal cancer	3.23e-06	3.64e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—NOS3—esophageal cancer	3.2e-06	3.6e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GNG7—esophageal cancer	3.07e-06	3.46e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HMOX1—esophageal cancer	3.04e-06	3.42e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS2—esophageal cancer	2.95e-06	3.33e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS2—esophageal cancer	2.92e-06	3.29e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MYC—esophageal cancer	2.9e-06	3.27e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.88e-06	3.24e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.86e-06	3.22e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGFR—esophageal cancer	2.84e-06	3.2e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP1B1—esophageal cancer	2.83e-06	3.19e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—EP300—esophageal cancer	2.79e-06	3.14e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.76e-06	3.11e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CA—esophageal cancer	2.75e-06	3.1e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.74e-06	3.09e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.71e-06	3.05e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—EP300—esophageal cancer	2.7e-06	3.04e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP19A1—esophageal cancer	2.66e-06	3e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CREBBP—esophageal cancer	2.58e-06	2.91e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.57e-06	2.89e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ENO1—esophageal cancer	2.57e-06	2.89e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PSME1—esophageal cancer	2.53e-06	2.85e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PSME2—esophageal cancer	2.53e-06	2.85e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CA—esophageal cancer	2.47e-06	2.78e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—EP300—esophageal cancer	2.46e-06	2.77e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CREBBP—esophageal cancer	2.44e-06	2.75e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—EP300—esophageal cancer	2.43e-06	2.74e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HMOX1—esophageal cancer	2.43e-06	2.73e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.38e-06	2.68e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ABCB1—esophageal cancer	2.33e-06	2.62e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NOS3—esophageal cancer	2.31e-06	2.61e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NOS3—esophageal cancer	2.19e-06	2.46e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.18e-06	2.46e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS2—esophageal cancer	2.12e-06	2.38e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CA—esophageal cancer	2.06e-06	2.33e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.05e-06	2.31e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS2—esophageal cancer	2e-06	2.25e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CA—esophageal cancer	2e-06	2.25e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CREBBP—esophageal cancer	1.95e-06	2.2e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.87e-06	2.11e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CA—esophageal cancer	1.82e-06	2.05e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CA—esophageal cancer	1.8e-06	2.03e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.8e-06	2.02e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.76e-06	1.98e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—EP300—esophageal cancer	1.76e-06	1.98e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NOS3—esophageal cancer	1.75e-06	1.97e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—EP300—esophageal cancer	1.66e-06	1.87e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS2—esophageal cancer	1.6e-06	1.8e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CREBBP—esophageal cancer	1.56e-06	1.75e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NOS3—esophageal cancer	1.39e-06	1.57e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—EP300—esophageal cancer	1.33e-06	1.5e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CA—esophageal cancer	1.3e-06	1.47e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.27e-06	1.44e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CA—esophageal cancer	1.23e-06	1.39e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.2e-06	1.35e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NOS3—esophageal cancer	1.08e-06	1.21e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—EP300—esophageal cancer	1.06e-06	1.19e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS2—esophageal cancer	9.84e-07	1.11e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CA—esophageal cancer	9.82e-07	1.11e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—EP300—esophageal cancer	8.18e-07	9.22e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CA—esophageal cancer	7.84e-07	8.83e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	6.05e-07	6.82e-06	CbGpPWpGaD
